Evaluation of access to medicines in preferential trade agreements: from the Trans-Pacific Partnership to the Comprehensive and Progressive Agreement for Trans-Pacific Partnership. In: IIC – International Review of Intellectual Property and Competition Law; 2018. Figure 4. China`s trade profile. China`s IT to their partners (above) and the partner to China (below) during the five-year period following the effective date of the respective BTA. In the left and right boxes, the results are displayed for the export (import) links. China`s partners with a BTA include Chile (CHL), Hong Kong (HKG), New Zealand (NZL), Pakistan (HAP) and the Association of South Asian Nations (AS). The values of the red (purple) score parameter below imply a higher (lower) TI level during the 5-year period after tf. Trade agreements in the red (purple) regions indicate a positive (negative) IT trend between TF partners. There is a large amount of literature analysing the potential negative effects of intellectual property rules contained in different trade agreements on access to medicines and the functioning of those rules (see, for example.B.

[1, 4,5,6]]. . . .